SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart

Lymphoma Clinical Trial

Official title: SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart

Status Completed

Clinical Trial Summary

This pilot trial studies how well education and mobile health applications work in reducing the effects of cancer treatment on the heart in participants with blood cancers that are in remission. Education and mobile health applications may be effective ways to manage heart health and to reduce future heart disease risk in participants with blood cancers.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. Determine the feasibility of recruiting and retaining hematologic malignancy and hematopoietic cell transplantation (HCT) survivors in a randomized cardiovascular (CV) risk reduction mobile health (mHealth) counseling intervention.

II. Develop and refine a protocol to engage participants using an existing social medial platform and commercially available mHealth tools to reinforce lifestyle goals.

OUTLINE: Participants are randomized to 1 of 2 groups.

INTERVENTION GROUP: Participants receive individualized goal-setting and coaching in relation to physical activity and diet, supplemented with peer support through the study's social media platform, over 4 months. They also have access to mHealth apps including Fitbit and Healthwatch that provide feedback on physical activity and diet.

CONTROL GROUP: Participants receive general information about physical activity and diet, and access to Fitbit and Healthwatch.

After completion of study treatment, participants are followed up at 2 months and at 1 year. ;

Related Conditions & MeSH terms

• Acute Leukemia in Remission
• Hematopoietic Cell Transplantation Recipient
• Lymphoma

• NCT number: NCT03574012
• Study type: Interventional
• Source: Fred Hutchinson Cancer Center
• Status: Completed
• Phase: N/A
• Start date: August 31, 2018
• Completion date: June 16, 2020